商品描述
This reference book discusses the role of synbiotics in a wide range of disease states, including cardiovascular, reproductive, metabolic, neurodegenerative, gastrointestinal, thrombotic, skin, and inflammatory disorders. It reviews the functions of probiotics in the diagnosis, prevention, or treatment of various disease states. The book further covers improving the targeting efficiency of synbiotics through advanced drug delivery systems such as nanoparticles, microparticles, liposomes, microemulsion, solid lipid nanoparticles, and nano lipid carriers. The chapter addresses the implications of oral and topical delivery of synbiotics in different diseases and presents the safety assessment of synbiotics and clinical trials associated with synbiotics containing drug delivery systems for the treatment of diseases. The book also explores the synergistic welfare of synbiotics nutraceuticals in various conditions such as chronic respiratory diseases, gut health, and neurological functions and examines the toxicological profile, and regulatory aspects of nutraceutical supplements. As such, this book is a valuable resource for academics, research and industry professionals working in Pharmaceutical Sciences, Food Biotechnology, Immunology, and Health Sciences.
商品描述(中文翻譯)
這本參考書討論了益生元在各種疾病狀態中的作用，包括心血管、生殖、代謝、神經退行性、腸胃、血栓、皮膚和發炎性疾病。它回顧了益生菌在診斷、預防或治療各種疾病狀態中的功能。該書進一步介紹了通過納米粒子、微粒子、脂質體、微乳、固體脂質納米粒子和納米脂質載體等先進的藥物傳遞系統來提高益生元的靶向效率。該章節討論了益生元口服和局部傳遞在不同疾病中的影響，並提出了益生元的安全評估和與包含藥物傳遞系統的益生元相關的臨床試驗，用於治療疾病。該書還探討了益生元營養補品在慢性呼吸道疾病、腸道健康和神經功能等各種情況下的協同效益，並檢查了營養補品的毒理學概況和監管方面。因此，這本書對於從事藥學科學、食品生物技術、免疫學和健康科學的學術界、研究和行業專業人士來說是一個寶貴的資源。
作者簡介
Dr. Kamal Dua is a Senior Lecturer in the Discipline of Pharmacy at the Graduate School of Health, University of Technology Sydney (UTS), Australia. He has research experience of over 12 years in the field of drug delivery systems targeting inflammatory diseases. Dr. Dua is also a Node Leader of Drug Delivery Research in the Centre for Inflammation at Centenary Institute/UTS, where the targets identified from the research projects are pursued to develop novel formulations as the first step towards translation into clinics. Dr. Dua researches in two complementary areas; drug delivery and immunology, specifically addressing how these disciplines can advance one another, helping the community to live longer and healthier. This is evidenced by his extensive publication record in reputed journals. Dr. Dua's research interests focus on harnessing the pharmaceutical potential of modulating critical regulators such as Interleukins and microRNAs and developing new and effective drug delivery formulations for the management of chronic airway diseases. He has published more than 440 research articles in peer-reviewed international journals and authored or co-authored four books. He is an active member of many national and international professional societies.
作者簡介(中文翻譯)
Dr. Kamal Dua 是澳洲悉尼科技大學（UTS）健康研究生院藥學學科的高級講師。他在藥物傳遞系統針對炎症性疾病的研究領域擁有超過12年的經驗。Dr. Dua 也是Centenary Institute/UTS炎症中心藥物傳遞研究的節點負責人，該研究項目中確定的目標將被追求以開發新型配方，作為轉化為臨床的第一步。Dr. Dua 的研究涉及兩個互補的領域：藥物傳遞和免疫學，特別是探討這些學科如何相互促進，幫助社區更長壽、更健康。這在他在知名期刊上的廣泛發表記錄中有所體現。Dr. Dua 的研究興趣集中在利用調節介白素和微小核糖核酸等關鍵調節因子的藥物潛力，以及開發用於慢性呼吸道疾病管理的新型有效藥物傳遞配方。他在同行評審的國際期刊上發表了440多篇研究文章，並撰寫或合著了四本書。他是許多國內外專業學會的活躍成員。
